Encompass Health Co. (NYSE:EHC) Shares Acquired by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC boosted its holdings in Encompass Health Co. (NYSE:EHC) by 12.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,851 shares of the company’s stock after buying an additional 1,232 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Encompass Health were worth $914,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of Encompass Health by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company’s stock worth $839,520,000 after acquiring an additional 169,113 shares during the last quarter. Wellington Management Group LLP raised its holdings in Encompass Health by 5.8% during the 4th quarter. Wellington Management Group LLP now owns 8,215,770 shares of the company’s stock worth $548,156,000 after buying an additional 449,230 shares during the period. TD Asset Management Inc lifted its stake in Encompass Health by 16.0% during the first quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock valued at $188,586,000 after buying an additional 314,488 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Encompass Health by 1.2% in the second quarter. Dimensional Fund Advisors LP now owns 1,819,345 shares of the company’s stock worth $156,083,000 after buying an additional 22,311 shares during the period. Finally, Epoch Investment Partners Inc. increased its position in shares of Encompass Health by 14.2% in the first quarter. Epoch Investment Partners Inc. now owns 1,598,042 shares of the company’s stock worth $131,966,000 after acquiring an additional 198,701 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on EHC shares. Truist Financial upped their price target on shares of Encompass Health from $100.00 to $104.00 and gave the company a “buy” rating in a research report on Thursday, August 15th. Barclays decreased their target price on Encompass Health from $113.00 to $109.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a research report on Wednesday, July 10th. Stephens reissued an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. Finally, Leerink Partners began coverage on Encompass Health in a research note on Wednesday, July 10th. They set an “outperform” rating and a $100.00 target price on the stock. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $100.38.

Insider Buying and Selling

In other news, CFO Douglas E. Coltharp sold 12,260 shares of Encompass Health stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now owns 136,227 shares of the company’s stock, valued at $11,761,839.18. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Trading Up 0.2 %

NYSE:EHC opened at $92.82 on Tuesday. The company has a market capitalization of $9.35 billion, a P/E ratio of 25.09, a P/E/G ratio of 1.39 and a beta of 0.88. The stock’s 50 day moving average price is $90.19 and its 200 day moving average price is $85.49. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $94.59.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.10. The business had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.30 billion. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. Encompass Health’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.95 EPS. On average, research analysts forecast that Encompass Health Co. will post 4.18 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.73%. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 18.38%.

Encompass Health declared that its Board of Directors has approved a stock repurchase program on Wednesday, July 24th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 5.4% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.